{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:25:57Z","timestamp":1771331157657,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jocn.2020.04.026","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T07:47:18Z","timestamp":1587541638000},"page":"236-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Smoking-cessation pharmacotherapy for patients with stroke and TIA: Systematic review"],"prefix":"10.1016","volume":"78","author":[{"given":"Neal S.","family":"Parikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setareh","family":"Salehi Omran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hooman","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell S.V.","family":"Elkind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua Z.","family":"Willey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2020.04.026_b0005","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1212\/WNL.0000000000004617","article-title":"Increasing prevalence of vascular risk factors in patients with stroke: a call to action","volume":"89","author":"Otite","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2020.04.026_b0010","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/jamaneurol.2017.0020","article-title":"Prevalence of cardiovascular risk factors and strokes in younger adults","volume":"74","author":"George","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jocn.2020.04.026_b0015","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1212\/01.wnl.0000176058.09848.bb","article-title":"Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly","volume":"65","author":"Kaplan","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2020.04.026_b0020","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1161\/STROKEAHA.112.668905","article-title":"Baseline smoking status and the long-term risk of death or nonfatal vascular event in people with stroke: a 10-year survival analysis","volume":"43","author":"Kim","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2020.04.026_b0025","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000091224","article-title":"Effect of smoking status on outcome after acute ischemic stroke","volume":"21","author":"Ovbiagele","year":"2006","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jocn.2020.04.026_b0030","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1161\/01.STR.0000185686.28035.d2","article-title":"Incidence of recurrent subarachnoid hemorrhage after clipping for ruptured intracranial aneurysms","volume":"36","author":"Wermer","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2020.04.026_b0035","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1212\/WNL.0000000000004524","article-title":"Smoking cessation and outcome after ischemic stroke or TIA","volume":"89","author":"Epstein","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2020.04.026_b0040","first-page":"CD009329","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","author":"Cahill","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jocn.2020.04.026_b0045","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2020.04.026_b0050","doi-asserted-by":"crossref","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke. 2019:STR0000000000000211.","DOI":"10.1161\/STR.0000000000000211"},{"issue":"25","key":"10.1016\/j.jocn.2020.04.026_b0055","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/j.jacc.2018.10.027","article-title":"2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American college of cardiology task force on clinical expert consensus documents","volume":"72","author":"Barua","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jocn.2020.04.026_b0060","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.115.002458","article-title":"Efficacy and safety of smoking cessation interventions in patients with cardiovascular disease: a network meta-analysis of randomized controlled trials","volume":"10","author":"Suissa","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jocn.2020.04.026_b0065","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/jamainternmed.2018.0397","article-title":"Cardiovascular safety of varenicline, bupropion, and nicotine patch in smokers: a randomized clinical trial","volume":"178","author":"Benowitz","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jocn.2020.04.026_b0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.115.019634","article-title":"Varenicline for smoking cessation in hospitalized patients with acute coronary syndrome","volume":"133","author":"Eisenberg","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jocn.2020.04.026_b0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/00981389.2012.745460","article-title":"Predictors of smoking patterns after first stroke","volume":"52","author":"McCarthy","year":"2013","journal-title":"Soc Work Health Care"},{"key":"10.1016\/j.jocn.2020.04.026_b0080","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000338280","article-title":"Reasons for quitting smoking in patients with first-ever ischemic stroke","volume":"18","author":"Sienkiewicz-Jarosz","year":"2012","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.jocn.2020.04.026_b0085","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/ntr\/ntx046","article-title":"Immediate and sustained decrease in smoking urges after acute insular cortex damage","volume":"19","author":"Abdolahi","year":"2017","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.jocn.2020.04.026_b0090","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/ntr\/ntt172","article-title":"Basal ganglia plus insula damage yields stronger disruption of smoking addiction than basal ganglia damage alone","volume":"16","author":"Gaznick","year":"2014","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.jocn.2020.04.026_b0095","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jclinepi.2005.05.003","article-title":"The diagnosis of a smoking-related disease is a prominent trigger for smoking cessation in a retrospective cohort study","volume":"59","author":"Twardella","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jocn.2020.04.026_b0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ypmed.2018.10.010","article-title":"Does outpatient cardiac rehabilitation help patients with acute myocardial infarction quit smoking?","volume":"118","author":"Katz","year":"2019","journal-title":"Prev Med"},{"key":"10.1016\/j.jocn.2020.04.026_b0105","doi-asserted-by":"crossref","first-page":"H1518","DOI":"10.1152\/ajpheart.00928.2010","article-title":"Nicotine aggravates the brain postischemic inflammatory response","volume":"300","author":"Bradford","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jocn.2020.04.026_b0110","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1124\/jpet.109.157776","article-title":"Nicotine exacerbates brain edema during in vitro and in vivo focal ischemic conditions","volume":"332","author":"Paulson","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jocn.2020.04.026_b0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00004647-199702000-00002","article-title":"Chronic nicotine treatment enhances focal ischemic brain injury and depletes free pool of brain microvascular tissue plasminogen activator in rats","volume":"17","author":"Wang","year":"1997","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jocn.2020.04.026_b0120","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/STROKEAHA.117.020178","article-title":"Population-based assessment of the long-term risk of seizures in survivors of stroke","volume":"49","author":"Merkler","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2020.04.026_b0125","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2165\/00002018-200831110-00006","article-title":"Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004","volume":"31","author":"Beyens","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.jocn.2020.04.026_b0130","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1212\/WNL.0000000000001514","article-title":"Poststroke suicide attempts and completed suicides: a socioeconomic and nationwide perspective","volume":"84","author":"Eriksson","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jocn.2020.04.026_b0135","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007830","article-title":"Risk of suicide attempt in poststroke patients: a population-based cohort study","volume":"7","author":"Harnod","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jocn.2020.04.026_b0140","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jocn.2020.04.026_b0145","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jocn.2020.04.026_b0150","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2011-000366","article-title":"A randomised controlled pilot study of standardised counselling and cost-free pharmacotherapy for smoking cessation among stroke and TIA patients","volume":"1","author":"Papadakis","year":"2011","journal-title":"BMJ Open"},{"key":"10.1016\/j.jocn.2020.04.026_b0155","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/ntr\/ntr233","article-title":"Smoking cessation intervention after ischemic stroke or transient ischemic attack. A randomized controlled pilot trial","volume":"14","author":"Brunner Frandsen","year":"2012","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.jocn.2020.04.026_b0160","doi-asserted-by":"crossref","first-page":"610","DOI":"10.4040\/jkan.2016.46.4.610","article-title":"Timely interventions can increase smoking cessation rate in men with ischemic stroke","volume":"46","author":"Lee","year":"2016","journal-title":"J Korean Acad Nurs"},{"key":"10.1016\/j.jocn.2020.04.026_b0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.healthpol.2014.11.017","article-title":"Nationwide smoking cessation treatment support program-Turkey project","volume":"119","author":"\u00c7elik","year":"2015","journal-title":"Health Policy"},{"key":"10.1016\/j.jocn.2020.04.026_b0170","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/tc.2005.011387","article-title":"Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death","volume":"14","author":"Hubbard","year":"2005","journal-title":"Tob Control"},{"key":"10.1016\/j.jocn.2020.04.026_b0175","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1161\/STROKEAHA.111.620955","article-title":"Nicotine replacement therapy after subarachnoid hemorrhage is not associated with increased vasospasm","volume":"42","author":"Carandang","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2020.04.026_b0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12028-010-9456-9","article-title":"Transdermal nicotine replacement therapy in cigarette smokers with acute subarachnoid hemorrhage","volume":"14","author":"Seder","year":"2011","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.jocn.2020.04.026_b0185","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2146\/ajhp090402","article-title":"Outcomes associated with transdermal nicotine replacement therapy in a neurosurgery intensive care unit","volume":"67","author":"Panos","year":"2010","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"10.1016\/j.jocn.2020.04.026_b0190","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002022","article-title":"The effectiveness of smoking cessation interventions in smokers with cerebrovascular disease: a systematic review","volume":"2","author":"Edjoc","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.jocn.2020.04.026_b0195","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jocn.2017.03.014","article-title":"Nicotine replacement therapy in patients with aneurysmal subarachnoid hemorrhage: systematic review of the literature, and survey of Canadian practice","volume":"42","author":"Turgeon","year":"2017","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2020.04.026_b0200","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCULATIONAHA.109.869008","article-title":"Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial","volume":"121","author":"Rigotti","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jocn.2020.04.026_b0205","doi-asserted-by":"crossref","first-page":"E347","DOI":"10.1503\/cmaj.170377","article-title":"Smoking abstinence 1 year after acute coronary syndrome: follow-up from a randomized controlled trial of varenicline in patients admitted to hospital","volume":"190","author":"Windle","year":"2018","journal-title":"CMAJ"},{"key":"10.1016\/j.jocn.2020.04.026_b0210","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0195-668X(03)00003-4","article-title":"Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study","volume":"24","author":"Tonstad","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jocn.2020.04.026_b0215","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1126\/science.1135926","article-title":"Damage to the insula disrupts addiction to cigarette smoking","volume":"315","author":"Naqvi","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jocn.2020.04.026_b0220","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/HJR.0b013e3282f4b212","article-title":"Depression: a predictor of smoking relapse in a 6-month follow-up after hospitalization for acute coronary syndrome","volume":"15","author":"Perez","year":"2008","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.jocn.2020.04.026_b0225","unstructured":"Pfizer Labs. CHANTIX (varenicline) [package insert]. http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=557#S6.2. Accessed April 15, 2019."},{"key":"10.1016\/j.jocn.2020.04.026_b0230","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2020.04.026_b0235","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1164\/rccm.201706-1204OC","article-title":"Cardiovascular and neuropsychiatric events after varenicline use for smoking cessation","volume":"197","author":"Gershon","year":"2018","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586820302435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586820302435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:24:46Z","timestamp":1760822686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586820302435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":47,"alternative-id":["S0967586820302435"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2020.04.026","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Smoking-cessation pharmacotherapy for patients with stroke and TIA: Systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2020.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}